Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Gene Panels for Intraocular Lymphoma Can Overcome Diagnostic Difficulties and Enable Precision Medicine

Kazuki Taoka, Arika Shimura-Nukina, Akira Honda, Yosuke Masamoto, Mineo Kurokawa

Blood (2023) 142 (Supplement 1): 5030.

https://doi.org/10.1182/blood-2023-187872

Published: 2023

Journal Articles

Novel Prediction Models for Myelodysplastic Syndromes Using Machine Learning

Kazuki Taoka, Ayumu Tsubosaka, Kumi Nakazaki, Akira Honda, Hiroaki Maki, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2021-151759

Published: 2021

Journal Articles

Novel Recurrent Mutations in Eldheim-Chester Disease Patients Identified By Whole Exome Sequencing and Whole Genome Sequencing

Yu Oyama, Akira Honda, Kensuke Matsuda, Hideaki Mizuno, Kazuki Taoka, Mineo Kurokawa

Blood (2021) 138 (Supplement 1): 3123.

https://doi.org/10.1182/blood-2021-149864

Published: 2021

Journal Articles

Calcium/Calmodulin Dependent Protein Kinase 2 Gamma Is Identified As a Potential Therapeutic Target of Myelofibrosis Using Disease-Specific Induced Pluripotent Stem Cells

Masashi Miyauchi, MD PhD, Ken Sasaki, MD, Kazuki Taoka, MD PhD, Yosuke Masamoto, MD PhD, Sho Yamazaki, MD PhD, Shunya Arai, MD PhD, Mineo Kurokawa, MD PhD

Blood (2018) 132 (Supplement 1): 3054.

https://doi.org/10.1182/blood-2018-99-113285

Published: 2018

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Identified SLITRK4 As a Causative Gene of Chronic Myelomonocytic Leukemia

Sho Yamazaki, MD, PhD, Kazuki Taoka, MD, PhD, Shunya Arai, MD, PhD, Masashi Miyauchi, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1134.

https://doi.org/10.1182/blood.V128.22.1134.1134

Published: 2016

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Masashi Miyauchi, MD, PhD, Shunya Arai, MD, PhD, Akira Honda, MD PhD, Sho Yamazaki, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Kazuki Taoka, MD, PhD, Keiki Kumano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1878.

https://doi.org/10.1182/blood.V128.22.1878.1878

Published: 2016

Journal Articles

Disease-Specific Induced Pluripotent Stem Cells Recapitulate The Pathophysiology Of Familial Platelet Disorder With Predisposition To Acute Myelogenous Leukemia

Shunya Arai, MD, PhD, Hiromitsu Iiduka, MD, Naoya Takayama, M.D., Ph.D., Miyauchi Masashi, MD, Kazuki Taoka, MD, PhD, Keisuke Kataoka, MD, PhD, Masataka Hosoi, MD, PhD, Keiki Kumano, MD, PhD, Koji Eto, M.D., Ph.D., Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 1188.

https://doi.org/10.1182/blood.V122.21.1188.1188

Published: 2013

Journal Articles

Modeling Chronic Myelomonocytic Leukemia Through Patient-Derived Induced Pluripotent Stem Cells

Keisuke Kataoka, MD, PhD, Kazuki Taoka, MD, PhD, Masashi Miyauchi, M.D., Ph.D., Masataka Hosoi, M.D., Ph.D., Keiki Kumano, MD, PhD, Shunya Arai, MD, PhD, Kazuhiro Toyama, M.D., Ph.D., Genta Nagae, M.D., Ph.D., Wei Qu, Ph.D., Shinichi Morishita, Ph.D., Hiroyuki Aburatani, M.D., Ph.D., Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 864.

https://doi.org/10.1182/blood.V122.21.864.864

Published: 2013

Journal Articles

The shortest isoform of C/EBPβ , liver inhibitory protein ( LIP ), collaborates with Evi1 to induce AML in a mouse BMT model

Naoko Watanabe-Okochi, Akihide Yoshimi, Tomohiko Sato, Toshiyuki Ikeda, Keiki Kumano, Kazuki Taoka, Yumiko Satoh, Akihito Shinohara, Takako Tsuruta, Akiko Masuda, Hiromitsu Yokota, Yutaka Yatomi, Koki Takahashi, Jiro Kitaura, Toshio Kitamura, Mineo Kurokawa

Blood (2013) 121 (20): 4142–4155.

https://doi.org/10.1182/blood-2011-07-368654

Published: 2013

Includes: Supplemental data

Journal Articles

Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples

Keiki Kumano, Shunya Arai, Masataka Hosoi, Kazuki Taoka, Naoya Takayama, Makoto Otsu, Genta Nagae, Koki Ueda, Kumi Nakazaki, Yasuhiko Kamikubo, Koji Eto, Hiroyuki Aburatani, Hiromitsu Nakauchi, Mineo Kurokawa

Blood (2012) 119 (26): 6234–6242.

https://doi.org/10.1182/blood-2011-07-367441

Published: 2012

Includes: Supplemental data

NARROW

Gene Panels for Intraocular Lymphoma Can Overcome Diagnostic Difficulties and Enable Precision Medicine

Novel Prediction Models for Myelodysplastic Syndromes Using Machine Learning

Novel Recurrent Mutations in Eldheim-Chester Disease Patients Identified By Whole Exome Sequencing and Whole Genome Sequencing

Calcium/Calmodulin Dependent Protein Kinase 2 Gamma Is Identified As a Potential Therapeutic Target of Myelofibrosis Using Disease-Specific Induced Pluripotent Stem Cells

Patient-Derived Induced Pluripotent Stem Cells Identified SLITRK4 As a Causative Gene of Chronic Myelomonocytic Leukemia

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Disease-Specific Induced Pluripotent Stem Cells Recapitulate The Pathophysiology Of Familial Platelet Disorder With Predisposition To Acute Myelogenous Leukemia

Modeling Chronic Myelomonocytic Leukemia Through Patient-Derived Induced Pluripotent Stem Cells

The shortest isoform of C/EBPβ , liver inhibitory protein ( LIP ), collaborates with Evi1 to induce AML in a mouse BMT model

Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only